1
|
Mukhtar A, Shah S, Kanwal, Khan KM, Khan SU, Zaib S, Iqbal J, Parveen S, Taha M, Hussain S, Hameed S, Khan NA, Siddiqui R, Anwar A. Synthesis of Chalcones as Potential
α
‐Glucosidase Inhibitors,
In‐Vitro
and
In‐Silico
Studies. ChemistrySelect 2021. [DOI: 10.1002/slct.202102434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Asma Mukhtar
- H. E. J. Research Institute of Chemistry International Center for Chemical and Biological Sciences University of Karachi Karachi 75270 Pakistan
| | - Shazia Shah
- H. E. J. Research Institute of Chemistry International Center for Chemical and Biological Sciences University of Karachi Karachi 75270 Pakistan
| | - Kanwal
- H. E. J. Research Institute of Chemistry International Center for Chemical and Biological Sciences University of Karachi Karachi 75270 Pakistan
- Institute of Marine Biotechnology Universiti Malaysia Terengganu 21030 Kuala Terengganu Malaysia
| | - Khalid Mohammed Khan
- H. E. J. Research Institute of Chemistry International Center for Chemical and Biological Sciences University of Karachi Karachi 75270 Pakistan
- Department of Clinical Pharmacy Institute for Research and Medical Consultations (IRMC) Imam Abdulrahman Bin Faisal University P.O. Box 1982 Dammam 31441 Saudi Arabia
| | - Shahid Ullah Khan
- Centre for Advanced Drug Research COMSATS University Islamabad Abbottabad Campus Abbottabad 22060 Pakistan
| | - Sumera Zaib
- Centre for Advanced Drug Research COMSATS University Islamabad Abbottabad Campus Abbottabad 22060 Pakistan
| | - Jamshed Iqbal
- Centre for Advanced Drug Research COMSATS University Islamabad Abbottabad Campus Abbottabad 22060 Pakistan
| | - Shahnaz Parveen
- PCSIR Laboratories Complex Karachi, Shahra-e-Dr. Salimuzzaman Siddiqui Karachi 75280 Pakistan
| | - Muhammad Taha
- Department of Clinical Pharmacy Institute for Research and Medical Consultations (IRMC) Imam Abdulrahman Bin Faisal University P.O. Box 1982 Dammam 31441 Saudi Arabia
| | - Shafqat Hussain
- Department of Chemistry University of Baltistan, Skardu, Main Campus Husainabad Kargil Road, Skardu Gilgit-Baltistan Pakistan
| | - Shahryar Hameed
- H. E. J. Research Institute of Chemistry International Center for Chemical and Biological Sciences University of Karachi Karachi 75270 Pakistan
| | - Naveed Ahmed Khan
- Department of Clinical Sciences College of Medicine University of Sharjah Sharjah 27272 United Arab Emirates
| | - Ruqaiyyah Siddiqui
- College of Arts and Sciences American University of Sharjah Sharjah 26666 United Arab Emirates
| | - Ayaz Anwar
- Department of Biological Sciences School of Medical and Life Sciences Sunway University Petaling Jaya 47500 Selangor Malaysia
| |
Collapse
|
2
|
Novel N-bridged pyrazole-1-carbothioamides with potential antiproliferative activity: design, synthesis, in vitro and in silico studies. Future Med Chem 2021; 13:1743-1766. [PMID: 34427113 DOI: 10.4155/fmc-2021-0066] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Thiazole-substituted pyrazole is an important structural feature of many bioactive compounds, including antiviral, antitubercular, analgesic and anticancer agents. Herein we describe an efficient and facile approach for the synthesis of two series of 36 novel N-bridged pyrazole-1-phenylthiazoles. The antiproliferative activity of a set of representative compounds was evaluated in vitro against different human cancer cell lines. Among the identified compounds, compound 18 showed potent anticancer activity against the examined cancer cell lines. The in silico molecular docking study revealed that compound 18 possesses high binding affinity toward both SK1 and CDK2. Overall, these results indicate that compound 18 is a promising lead anticancer compound which may be exploited for development of antiproliferative drugs.
Collapse
|
3
|
Silakari P, Priyanka, Piplani P. p-Benzoquinone as a Privileged Scaffold of Pharmacological Significance: A Review. Mini Rev Med Chem 2020; 20:1586-1609. [DOI: 10.2174/1389557520666200429101451] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2019] [Revised: 02/11/2020] [Accepted: 02/13/2020] [Indexed: 12/20/2022]
Abstract
Quinones are a huge class of compounds with affluent and captivating chemistry.
p-Benzoquinone (p-BNZ) or 1,4-Benzoquinone is the key structural motif of numerous biologically active
synthetic and natural compounds. This draws interest in its biological exploration to assess prospective
therapeutic implications. It possesses immense therapeutic potential depending on different
substitutions. This moiety has a marvelous potential to regulate a varied range of different cellular
pathways which can be investigated for various selective activities. p-Benzoquinones have been a requisite
core for the development of novel therapeutic molecules with minimum side effects. In this review,
various synthetic, pharmacological approaches and structure-activity relationship studies focusing
on the chemical groups responsible for evoking the pharmacological potential of p-benzoquinone
derivatives have been emphasized. Additionally, the compilation highlights the chemical, pharmaceutical
and medicinal aspects of synthetic and natural benzoquinone derivatives. The natural occurrences
of p-benzoquinone derivatives with different pharmacological significance have also been reported in
this review.
Collapse
Affiliation(s)
- Pragati Silakari
- Department of Pharmaceutical Chemistry, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh- 160014, India
| | - Priyanka
- Department of Pharmaceutical Chemistry, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh- 160014, India
| | - Poonam Piplani
- Department of Pharmaceutical Chemistry, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh- 160014, India
| |
Collapse
|
4
|
Bioactivity Profile of the Diterpene Isosteviol and its Derivatives. Molecules 2019; 24:molecules24040678. [PMID: 30769819 PMCID: PMC6412665 DOI: 10.3390/molecules24040678] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2019] [Revised: 02/03/2019] [Accepted: 02/06/2019] [Indexed: 12/24/2022] Open
Abstract
Steviosides, rebaudiosides and their analogues constitute a major class of naturally occurring biologically active diterpene compounds. The wide spectrum of pharmacological activity of this group of compounds has developed an interest among medicinal chemists to synthesize, purify, and analyze more selective and potent isosteviol derivatives. It has potential biological applications and improves the field of medicinal chemistry by designing novel drugs with the ability to cope against resistance developing diseases. The outstanding advancement in the design and synthesis of isosteviol and its derivative has proved its effectiveness and importance in the field of medicinal chemical research. The present review is an effort to integrate recently developed novel drugs syntheses from isosteviol and potentially active pharmacological importance of the isosteviol derivatives covering the recent advances.
Collapse
|
5
|
Shamsuzzaman, Siddiqui T, Alam MG, Dar AM. Synthesis, characterization and anticancer studies of new steroidal oxadiazole, pyrrole and pyrazole derivatives. JOURNAL OF SAUDI CHEMICAL SOCIETY 2015. [DOI: 10.1016/j.jscs.2012.04.009] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
6
|
Zhu SL, Wu Y, Liu CJ, Wei CY, Tao JC, Liu HM. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents. Eur J Med Chem 2013; 65:70-82. [DOI: 10.1016/j.ejmech.2013.04.044] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2013] [Revised: 04/19/2013] [Accepted: 04/20/2013] [Indexed: 11/27/2022]
|
7
|
Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents. Bioorg Med Chem Lett 2013; 23:1343-6. [DOI: 10.1016/j.bmcl.2012.12.091] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2012] [Revised: 12/17/2012] [Accepted: 12/25/2012] [Indexed: 11/20/2022]
|
8
|
Chaaban I, El Khawass ESM, Mahran MA, Abd El Razik HA, El Salamouni NS, Abdel Wahab AE. Synthesis and biological evaluation of novel hydroquinone dimethyl ethers as potential anticancer and antimicrobial agents. Med Chem Res 2012. [DOI: 10.1007/s00044-012-0337-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
9
|
Synthesis of 1-(4-aminosulfonylphenyl)-3,5-diarylpyrazoline derivatives as potent antiinflammatory and antimicrobial agents. Med Chem Res 2011. [DOI: 10.1007/s00044-011-9823-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
10
|
Molinari A, Oliva A, Ojeda C, del Corral JMM, Castro MA, Cuevas C, San Feliciano A. Synthesis and Cytotoxic Evaluation of 6-(3-Pyrazolylpropyl) Derivatives of 1,4-Naphthohydroquinone-1,4-diacetate. Arch Pharm (Weinheim) 2009; 342:591-9. [DOI: 10.1002/ardp.200900041] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
11
|
Al-Qahtani A, Siddiqui YM, Bekhit AA, El-Sayed OA, Aboul-Enein HY, Al-Ahdal MN. Inhibition of growth of Leishmania donovani promastigotes by newly synthesized 1,3,4-thiadiazole analogs. Saudi Pharm J 2009; 17:227-32. [PMID: 23964165 PMCID: PMC3731026 DOI: 10.1016/j.jsps.2009.08.005] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2008] [Accepted: 05/13/2009] [Indexed: 11/16/2022] Open
Abstract
Leishmania donovani, the causative agent of visceral leishmaniasis, is transmitted by sand flies and replicates intracellularly in their mammalian host cells. The emergence of drug-resistant strains has hampered efforts to control the spread of the disease worldwide. Forty-four 1,3,4-thiadiazole derivatives and related compounds were tested in vitro for possible anti-leishmanial activity against the promastigotes of L. donovani. Micromolar concentrations of these agents were used to study the inhibition of multiplication of L. donovani promastigotes. Seven compounds were identified with potential antigrowth agents of the parasite. Compound 4a was the most active at 50 μM followed by compound 3a. These compounds could prove useful as a future alternative for the control of visceral leishmaniasis.
Collapse
Affiliation(s)
- Ahmed Al-Qahtani
- Molecular Virology and Infectious Diseases Section, Department of Biological and Medical Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Yunus M. Siddiqui
- Molecular Virology and Infectious Diseases Section, Department of Biological and Medical Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Adnan A. Bekhit
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt
| | - Ola A. El-Sayed
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt
| | - Hassan Y. Aboul-Enein
- Pharmaceutical and Medicinal Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, Cairo 12311, Egypt
| | - Mohammed N. Al-Ahdal
- Molecular Virology and Infectious Diseases Section, Department of Biological and Medical Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
- Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| |
Collapse
|